Cargando…
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
RATIONALE: Several studies have suggested that modulation of the glutamatergic system via metabotropic glutamate receptors (mGlu) could be a new and efficient way to achieve antipsychotic-like activity. OBJECTIVES: Here, we decided to investigate the possible role of the group III mGlu receptor liga...
Autores principales: | Wierońska, Joanna M., Stachowicz, Katarzyna, Acher, Francine, Lech, Tomasz, Pilc, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299972/ https://www.ncbi.nlm.nih.gov/pubmed/21952670 http://dx.doi.org/10.1007/s00213-011-2502-2 |
Ejemplares similares
-
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT(1A) signalling
por: Wierońska, Joanna M., et al.
Publicado: (2013) -
Involvement of GABA(B) Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu(4) Receptor, LSP4-2022
por: Woźniak, Monika, et al.
Publicado: (2016) -
Mutual activation of glutamatergic mGlu(4) and muscarinic M(4) receptors reverses schizophrenia-related changes in rodents
por: Cieślik, Paulina, et al.
Publicado: (2018) -
On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
por: Pałucha-Poniewiera, Agnieszka, et al.
Publicado: (2010) -
Negative Allosteric Modulators of mGlu(7) Receptor as Putative Antipsychotic Drugs
por: Cieślik, Paulina, et al.
Publicado: (2018)